KPLPharmaceuticals
Kwality Pharmaceuticals Ltd — Cash Flow Statement
₹1306.35
-4.50%
Kwality Pharmaceuticals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 27.72 Cr | 13.14 Cr | -6.29 Cr | 5.44 Cr | — |
| Repayment Of Debt | -13.36 Cr | -11.26 Cr | -4.53 Cr | -12.34 Cr | — |
| Issuance Of Debt | 8.79 Cr | 4.06 Cr | 11.55 Cr | 20.92 Cr | — |
| Capital Expenditure | -25.00 Cr | -29.84 Cr | -47.67 Cr | -55.15 Cr | — |
| End Cash Position | 12.02 Cr | 2.26 Cr | 3.07 Cr | 9.13 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | -1000.00 | — | 1000.00 | — |
| Beginning Cash Position | 2.26 Cr | 3.07 Cr | 9.13 Cr | 5.81 Cr | — |
| Changes In Cash | 9.76 Cr | -0.81 Cr | -6.07 Cr | 3.33 Cr | — |
| Financing Cash Flow | -14.44 Cr | -17.40 Cr | 0.99 Cr | 5.66 Cr | — |
| Net Other Financing Charges | -1000.00 | — | 1000.00 | -2.92 Cr | — |
| Interest Paid Cff | -9.88 Cr | -10.20 Cr | -6.02 Cr | -2.92 Cr | — |
| Net Issuance Payments Of Debt | -4.56 Cr | -7.20 Cr | 7.01 Cr | 8.57 Cr | — |
| Net Long Term Debt Issuance | -4.56 Cr | -7.20 Cr | 7.01 Cr | 8.57 Cr | — |
| Long Term Debt Payments | -13.36 Cr | -11.26 Cr | -4.53 Cr | -12.34 Cr | — |
| Long Term Debt Issuance | 8.79 Cr | 4.06 Cr | 11.55 Cr | 14.37 Cr | — |
| Investing Cash Flow | -28.52 Cr | -26.40 Cr | -48.44 Cr | -62.93 Cr | — |
| Net Other Investing Changes | -3.75 Cr | -0.80 Cr | -2.75 Cr | -7.90 Cr | — |
| Interest Received Cfi | 0.16 Cr | 0.13 Cr | 0.12 Cr | 0.12 Cr | — |
| Net Intangibles Purchase And Sale | -1.71 Cr | — | — | — | — |
| Purchase Of Intangibles | -1.71 Cr | — | — | — | — |
| Net PPE Purchase And Sale | -23.22 Cr | -25.73 Cr | -45.81 Cr | -55.15 Cr | — |
| Sale Of PPE | 0.08 Cr | 4.11 Cr | 1.86 Cr | 0.00 | — |
| Purchase Of PPE | -23.29 Cr | -29.84 Cr | -47.67 Cr | -55.15 Cr | — |
| Operating Cash Flow | 52.72 Cr | 42.98 Cr | 41.38 Cr | 60.60 Cr | — |
| Taxes Refund Paid | -15.79 Cr | -1.30 Cr | -6.16 Cr | -41.35 Cr | — |
| Change In Working Capital | -13.64 Cr | -23.44 Cr | 1.01 Cr | -73.18 Cr | — |
| Change In Other Current Liabilities | 6.69 Cr | 16.12 Cr | -14.22 Cr | 10.27 Cr | — |
| Change In Other Current Assets | 13.67 Cr | -1.54 Cr | 50.07 Cr | -32.85 Cr | — |
| Change In Payable | 11.48 Cr | 9.12 Cr | 0.68 Cr | 8.30 Cr | — |
| Change In Inventory | -5.08 Cr | 2.73 Cr | -32.95 Cr | -36.00 Cr | — |
| Change In Receivables | -39.92 Cr | -42.69 Cr | -2.56 Cr | -49.80 Cr | — |
| Other Non Cash Items | 9.74 Cr | 17.06 Cr | 6.05 Cr | 2.79 Cr | — |
| Depreciation And Amortization | 18.29 Cr | 19.56 Cr | 14.96 Cr | 10.69 Cr | — |
| Depreciation | 18.29 Cr | 19.56 Cr | 14.96 Cr | 10.69 Cr | — |
| Gain Loss On Investment Securities | -0.03 Cr | -24000.00 | -0.05 Cr | — | 0.02 Cr |
| Net Income From Continuing Operations | 54.14 Cr | 31.10 Cr | 25.57 Cr | 161.57 Cr | — |
| Pension And Employee Benefit Expense | — | — | 0.15 Cr | 0.08 Cr | 0.06 Cr |
| Net Short Term Debt Issuance | — | — | — | 6.55 Cr | -6.64 Cr |
| Short Term Debt Issuance | — | — | — | 6.55 Cr | 357.95 Cr |
| Net Investment Purchase And Sale | — | — | — | -0.05 Cr | -0.13 Cr |
| Purchase Of Investment | — | — | — | -0.05 Cr | -0.13 Cr |
| Short Term Debt Payments | — | — | — | — | -364.58 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kwality Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.